Medivolve Inc MEDVF

Healthcare Copper

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.

OTCPK:MEDVF - Post by User

Medivolve Inc > All that revenue

<< Previous

Bullboard Posts

Next >>

Comment by Robotmeon Apr 05, 2022 6:17pm

90 Views

Post# 34578472

RE:RE:All that revenue

Maybe they'll collect, maybe not. A loss for the year is gnarly bad.

SY3XElon wrote: They had a ton of debt. Cut it from ($37,777,656) in 2020 to ($6,610,524) in 2021. Accounts receivables of $55,314,642 as of December 31st 2021 will wipe out the loss on the next report in May since the receivables will be collected as they are running 90 to 120 days to collect. I can't recall the exact number of receivables they expect not to collect to due return errors from insurance companies but it was marginal. You can verify everything written here from the financial report on SEDAR.

In short yes it is a net loss on Year End but Q1 thanks to the massive amount of receivables it's really not